A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs

Nanomedicine

Volumn 8, Issue 10, 2013, Pages 1587-1599

  Seras Franzoso, Joaquin ^b   Peebo, Karl ^b   Luis Corchero, José ^b   Tsimbouri, Penelope M ^b   Unzueta, Ugutz ^b   Rinas, Ursula ^b   Dalby, Matthew J ^b   Vazquez, Esther ^b   García Fruitós, Elena ^b   Villaverde, Antonio ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

biomaterial; building block; drug delivery; scaffold; tissue engineering

Indexed keywords

CLATHRIN; FIBROBLAST GROWTH FACTOR 2; HEAT SHOCK PROTEIN 70; NANOMATERIAL; POLYCAPROLACTONE; TISSUE SCAFFOLD;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIVISION; CELL PROLIFERATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; ESCHERICHIA COLI; FIBROBLAST; HUMAN; HUMAN CELL; IN VITRO STUDY; MECHANICAL STIMULATION; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TISSUE ENGINEERING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; DRUG DELIVERY SYSTEMS; ESCHERICHIA COLI; FIBROBLAST GROWTH FACTOR 2; HSP70 HEAT-SHOCK PROTEINS; HUMANS; INCLUSION BODIES; NANOSTRUCTURES; TISSUE ENGINEERING;

EID: 84879634206     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.12.188     Document Type: Article

References (67)

1. Molnar P, Wang W, Natarajan A, Rumsey JW, Hickman JJ. Photolithographic patterning of C2C12 myotubes using vitronectin as growth substrate in serum-free medium. Biotechnol. Prog. 23(1), 265-268 (2007).
2. Cha HJ, Hwang DS, Lim S. Development of bioadhesives from marine mussels. Biotechnol. J. 3(5), 631-638 (2008).
3. Hennessy KM, Clem WC, Phipps MC, Sawyer AA, Shaikh FM, Bellis SL. The effect of RGD peptides on osseointegration of hydroxyapatite biomaterials. Biomaterials 29(21), 3075-3083 (2008).
4. McMurray RJ, Gadegaard N, Tsimbouri PM et al. Nanoscale surfaces for the long-term maintenance of mesenchymal stem cell phenotype and multipotency. Nat. Mater. 10(8), 637-644 (2011).
5. Marcantonio NA, Boehm CA, Rozic RJ et al. The influence of tethered epidermal growth factor on connective tissue progenitor colony formation. Biomaterials 30(27), 4629-4638 (2009).
6. Zieris A, Prokoph S, Levental KR et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 31(31), 7985-7994 (2010).
7. Doschak MR, Kucharski CM, Wright JE, Zernicke RF, Uludag H. Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis. Mol. Pharm. 6(2), 634-640 (2009).
8. Jaklenec A, Hinckfuss A, Bilgen B, Ciombor DM, Aaron R, Mathiowitz E. Sequential release of bioactive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29(10), 1518-1525 (2008).
9. Madduri S, di Summa P, Papaloizos M, Kalbermatten D, Gander B. Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials 31(32), 8402-8409 (2010).
10. Bhang SH, Lee TJ, Lim JM et al. The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture. Biomaterials 30(1), 126-132 (2009).
11. Dodla MC, Bellamkonda RV. Differences between the effect of anisotropic and isotropic laminin and nerve growth factor presenting scaffolds on nerve regeneration across long peripheral nerve gaps. Biomaterials 29(1), 33-46 (2008).
12. Villaverde A, Carrio MM. Protein aggregation in recombinant bacteria: Biological role of inclusion bodies. Biotechnol. Lett. 25(17), 1385-1395 (2003).
13. Garcia-Fruitos E. Inclusion bodies: A new concept. Microb. Cell Fact. 9(1), 80 (2010).
14. Wu W, Xing L, Zhou B, Lin Z. Active protein aggregates induced by terminally attached self-assembling peptide ELK16 in Escherichia coli. Microb. Cell Fact. 10(1), 9 (2011).
15. Zhou B, Xing L, Wu W, Zhang XE, Lin Z. Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb. Cell Fact. 11(1), 10 (2012).
16. Ventura S, Villaverde A. Protein quality in bacterial inclusion bodies. Trends Biotechnol. 24(4), 179-185 (2006).
17. Garcia-Fruitos E, Vazquez E, Díez-Gil C et al. Bacterial inclusion bodies: Making gold from waste. Trends Biotechnol. 30(2), 65-70 (2012).
18. García-Fruitós E, Rodríguez-Carmona E, Díez-Gil C et al. Surface cell growth engineering assisted by a novel bacterial nanomaterial. Adv. Mater. 21, 4249-4253 (2009).
19. Garcia-Fruitos E, Seras-Franzoso J, Vazquez E, Villaverde A. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering. Nanotechnology 21(20), 205101 (2010).
20. Diez-Gil C, Krabbenborg S, Garcia-Fruitos E et al. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation. Biomaterials 31, 5805-5812 (2010).
21. Seras-Franzoso J, Diez-Gil C, Vazquez E et al. Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering. Nanomedicine (Lond.) 7(1), 79-93 (2012).
22. Vazquez E, Villaverde A. Engineering building blocks for self-assembling protein nanoparticles. Microb. Cell Fact. 9, 101 (2010).
23. Vazquez E, Corchero JL, Villaverde A. Post production protein stability: Trouble beyond the cell factory. Microb. Cell Fact. 10(1), 60 (2011).
24. Villaverde A. Nanotechnology, bionanotechnology and microbial cell factories. Microb. Cell Fact. 9, 53 (2010).
25. Rodriguez-Carmona E, Villaverde A. Nanostructured bacterial materials for innovative medicines. Trends MicroBiol. 18(9), 423-430 (2010).
26. Mitraki A. Protein aggregation from inclusion bodies to amyloid and biomaterials. Adv. Protein Chem. Struct. Biol. 79, 89-125 (2010).
27. Peternel S, Komel R. Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells. Microb. Cell Fact. 9, 66 (2010).
28. Peternel S, Komel R. Active protein aggregates produced in Escherichia coli. Int. J. Mol. Sci. 12(11), 8275-8287 (2011).
29. Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Recombinant protein solubility: Does more mean better? Nat. Biotechnol. 25(7), 718-720 (2007).
30. Garcia-Fruitos E, Gonzalez-Montalban N, Morell M et al. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins. Microb. Cell Fact. 4, 27 (2005).
31. Villaverde A, García-Fruitós E, Rinas U et al. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications. Microb. Cell Fact. 11, 76 (2012).
32. Liovic M, Ozir M, Bedina ZA, Peternel S, Komel R, Zupancic T. Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells. Microb. Cell Fact. 11(1), 67 (2012).
33. Vazquez E, Corchero JL, Burgueno JF et al. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies. Adv. Mater. 24(13), 1742-1747 (2012).
34. Maji SK, Perrin MH, Sawaya MR et al. Functional amyloids as natural storage of peptide hormones in pituitary secretory granules. Science 325(5938), 328-332 (2009).
35. Badtke MP, Hammer ND, Chapman MR. Functional amyloids signal their arrival. Sci. Signal. 2(80), e43 (2009).
36. Maji SK, Schubert D, Rivier C, Lee S, Rivier JE, Riek R. Amyloid as a depot for the formulation of long-acting drugs. PLoS Biol. 6(2), e17 (2008).
37. Ferrer-Miralles N, Corchero JL, Kumar P et al. Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine. Microb. Cell Fact. 10, 101 (2011).
38. Hoffmann F, van den Heuvel J, Zidek N, Rinas U. Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale. Enzyme Microb. Technol. 34, 235-241 (2004).
39. Rodriguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, Garcia-Fruitos E. Isolation of cell-free bacterial inclusion bodies. Microb.Cell Fact. 9(1), 71 (2010).
40. Garcia-Fruitos E, Aris A, Villaverde A. Localization of functional polypeptides in bacterial inclusion bodies. Appl. Environ. MicroBiol. 73(1), 289-294 (2007).
41. Peternel S, Grdadolnik J, Gaberc-Porekar V, Komel R. Engineering inclusion bodies for nondenaturing extraction of functional proteins. Microb. Cell Fact. 7(1), 34(2008).
42. Richard JP, Melikov K, Vives E et al. Cell penetrating peptides. A reevaluation of the mechanism of cellular uptake. J. Biol. Chem. 278(1), 585-590 (2003).
43. Lisi A, Briganti E, Ledda M et al. A combined synthetic-fibrin scaffold supports growth and cardiomyogenic commitment of human placental derived stem cells. PLoS ONE 7(4), e34284 (2012).
44. He S, Xia T, Wang H, Wei L, Luo X, Li X. Multiple release of polyplexes of plasmids VEGF and bFGF from electrospun fibrous scaffolds towards regeneration of mature blood vessels. Acta Biomater. 8(7), 2659-2669 (2012).
45. Diederichs S, Baral K, Tanner M, Richter W. Interplay between local versus soluble TGF beta and fibrin scaffolds: Role of cells and impact on human mesenchymal stem cell chondrogenesis. Tissue Eng. Part A 18(11-12), 1140-1150 (2012).
46. Zhao X, Hadjiargyrou M. Induction of cell migration in vitro by an electrospun PDGF BB/PLGA/PEG-PLA nanofibrous scaffold. J. Biomed. Nanotechnol. 7(6), 823-829 (2011).
47. Sokic S, Papavasiliou G. FGF-1 and proteolytically mediated cleavage site presentation influence three-dimensional fibroblast invasion in biomimetic PEGDA hydrogels. Acta Biomater. 8(6), 2213-2222 (2012).
48. Garcia-Fruitos E, Villaverde A. Friendly production of bacterial inclusion bodies. Korean J. Chem. Eng. 27(2), 385-389 (2010).
49. Hench LL, Polak JM. Third-generation biomedical materials. Science 295(5557), 1014-1017 (2002).
50. Seghezzi G, Patel S, Ren CJ et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J. Cell Biol. 141(7), 1659-1673 (1998).
51. Amalric F, Baldin V, Bosc-Bierne I et al. Nuclear translocation of basic fibroblast growth factor. Ann. NY Acad. Sci. 638, 127-138 (1991).
52. Bailly K, Soulet F, Leroy D, Amalric F, Bouche G. Uncoupling of cell proliferation and differentiation activities of basic fibroblast growth factor. FASEB J. 14(2), 333-344 (2000).
53. Cherny I, Gazit E. Amyloids: Not only pathological agents but also ordered nanomaterials. Angew. Chem. Int. Ed. Engl. 47(22), 4062-4069 (2008).
54. Morell M, Bravo R, Espargaro A et al. Inclusion bodies: Specificity in their aggregation process and amyloid-like structure. Biochem. Biophys. Acta 1783(10), 1815-1825 (2008).
55. Oberg K, Chrunyk BA, Wetzel R, Fink AL. Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR. Biochemistry 33(9), 2628-2634 (1994).
56. Gonzalez-Montalban N, Natalello A, Garcia Fruitos E, Villaverde A, Doglia SM. In situ protein folding and activation in bacterial inclusion bodies. Biotechnol. Bioeng. 100(4), 797-802 (2008).
57. Ami D, Natalello A, Taylor G, Tonon G, Maria DS. Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy. Biochem. Biophys. Acta 1764(4), 793-799 (2006).
58. Ami D, Natalello A, Gatti-Lafranconi P, LottíM, Doglia SM. Kinetics of inclusion body formation studied in intact cells by FT IR spectroscopy. FEBS Lett. 579(16), 3433-3436 (2005).
59. Garcia-Fruitos E, Martinez-Alonso M, Gonzalez-Montalban N, Valli M, Mattanovich D, Villaverde A. Divergent genetic control of protein solubility and conformational quality in Escherichia coli. J.?Mol. Biol. 374, 195-205 (2007).
60. Upadhyay AK, Murmu A, Singh A, Panda AK. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli. PLoS ONE 7(3), e33951 (2012).
61. Carrio M, Gonzalez-Montalban N, Vera A, Villaverde A, Ventura S. Amyloid-like properties of bacterial inclusion bodies. J.?Mol. Biol. 347(5), 1025-1037 (2005).
62. de Groot NS, Sabate R, Ventura S. Amyloids in bacterial inclusion bodies. Trends Biochem. Sci. 34(8), 408-416 (2009).
63. Corchero JL, Gasser B, Resina D et al. Unconventional microbial systems for the cost-efficient production of high-quality protein therapeutics. Biotechnol. Adv. doi:10.1016/j.biotechadv.2012.09.001 (2012) (Epub ahead of print).
64. Vera A, Gonzalez-Montalban N, Aris A, Villaverde A. The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol. Bioeng. 96(6), 1101-1106 (2007).
65. Martinez-Alonso M, Vera A, Villaverde A. Role of the chaperone DnaK in protein solubility and conformational quality in inclusion body-forming Escherichia coli cells. FEMS MicroBiol. Lett. 273(2), 187-195 (2007).
66. Martinez-Alonso M, Gonzalez-Montalban N, Garcia-Fruitos E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies. Microb. Cell Fact. 8(1), 4 (2009).
67. Platas G, Rodriguez-Carmona E, Garcia-Fruitos E, Cano-Garrido O, Villaverde A. Coproduction of GroELS discriminates between intrinsic and thermally-induced recombinant protein aggregation during substrate quality control. Microb. Cell Fact. 10(1), 79 (2011).